Comprehensive supply chain solutions for the Life Sciences
CryoPortal Login
  • English
Cryoport Systems logo
  • Industry Expertise
    • Cell Therapy
    • Gene Therapy
    • Biologics
    • Reproductive Medicine
      • Intended Parents
      • Clinics
    • Animal Health
      • Pharma & Biotech
      • Livestock
      • Companion Animal
  • Trusted Solutions
    • Shipping Systems
      • Cryogenic (below -150°C) Shipping Systems
        • Cryoport Express® Cryogenic Standard Shipping System
        • Cryoport Express® Cryogenic Combo Shipping System
        • Cryoport Express® Cryogenic HV3 Shipping System
        • Cryomax® Cryogenic Shipping System
      • Ultra Cold (-60 to -80°C) Shipping Systems
        • Cryoport Elite® Ultra Cold
      • Refrigerated (2 to 8°C) and CRT (15 to 25°C) Shipping Systems
        • Cryoport Express® C3™ Shipping System
      • Cryoport Accessories
        • Cryoport Safepak® System
    • Transportation
      • Clinical Drug Distribution
      • Commercial Drug Distribution
      • Cryoshuttle®
      • Reproductive Medicine Distribution
      • Animal Health Distribution
    • BioServices
      • Controlled Temperature Storage
      • Drug Packaging and Labelling
      • Kit Production
      • Biobanking
      • Clinical Sample Management
      • Drug Return & Destruction
      • Regulatory & QP Services
    • Consulting Services
      • Shipping Risk Assessment and Shipping Lane Qualification
      • Shipping System and Packaging Performance Qualification
      • Project/Program Management
      • Custom Packaging and Accessory Development
    • IntegriCell™ Cryopreservation
    • Data Services
  • Next-Gen Innovation
    • Cryoportal® 2
    • Cryoport Elite®
    • IntegriCell™ Cryopreservation
    • Integrated Supply Chain Centers
  • About Us
    • Our People
    • Management
    • Quality
    • Careers
    • Cryoport’s Family of Companies
  • Resources
    • Events
    • Supply Chain Blog
    • Company News & Articles
    • Brochures and Spec Sheets
    • Instructions
    • White Papers and Case Studies
    • Videos/Webinars
    • Reference Materials
      • Cryoportal® 2 Training Materials
      • Validation Package Request
      • Data Station Direction & Validation
      • Quality Change Notification Request
      • Smartpak II™ Airline Authorizations
  • Contact Us
    • Request a Quote
    • Locations
  • CYRX
CryoPortal Login
Request Info
Request a Quote
Request a Quote
Request Info Request a Quote

Supply Chain Archives

07/28/2025

Turning Risk into Resilience with Supply Chain Resilience for CDMOs

Contract Development and Manufacturing Organizations (CDMOs) are under more pressure than ever to deliver reliable results in an unpredictable world. From geopolitical instability to material shortages to increasingly complex regulatory expectations, the risks facing clinical and commercial programs have intensified. For CDMOs, these risks don’t just affect their own operations, they directly impact their clients’ ability to bring therapies to patients.

Read More

Read More
07/25/2025

Scaling with Confidence for CDMO Supply Chain Alignment

Contract Development and Manufacturing Organizations (CDMOs) play a critical role in the life sciences industry, enabling biopharma innovators to bring new therapies from development to manufacturing to patients around the world. The demand placed on CDMOs has only increased in recent years, especially as cell, gene, and biologic therapies have moved from concept to clinic at unprecedented speeds. While the technical and scientific capabilities of CDMOs have advanced to meet these challenges, one area remains a frequent source of friction and delay...the end-to-end, temperature-controlled supply chain.

Read More

Read More
07/24/2025

Building Better CDMO Supply Chain Readiness

With the accelerating growth of advanced therapies comes increasing complexity in the developing and manufacturing ecosystem. Contract Development and Manufacturing Organizations (CDMOs) sit at the center of this growth, providing critical manufacturing and development services on behalf of their clients, the therapeutic developers. CDMOs require the infrastructure and processes to efficiently scale production, maintain timelines, and ensure product integrity, all while navigating evolving regulatory expectations.

Read More

Read More

Categories

  • All (60)
  • Industry Insights (18)
  • Managing the Cold Chain (29)
  • Navigating Logistics (24)
  • Patient Access and Awareness (8)

Tags

  • Asia
  • Biologics
  • BioServices
  • Biostorage
  • CDMOs
  • Cell Therapy
  • Clinical Trials
  • Cold Chain Management
  • Commercialization
  • CROs
  • Cryopreservation
  • Europe
  • Gene Therapy
  • Global Logistics Tracking
  • Global Supply Chain Management
  • International Shipping
  • North America
  • Risk Mitigation
  • Standards and Compliance
  • Supply Chain Management

Subscribe to our newsletter

Never miss another update! Join our mailing list for all the latest news, events, and announcements.

  • Clinical Trial icon Trusted with 711 clinical trials
  • Approved therapies icons Supporting 18 approved therapies
  • Quality icon Robust quality standards
  • Client service icon 24/7/365 support team
  • About Us
  • Industries
  • Solutions
  • Resources
  • Innovation
  • Contact Us
  • About Us
  • Industries
  • Solutions
  • Resources
  • Innovation
  • Contact Us
Cryoport Systems logo
  • Privacy Policy
  • Terms of Use
  • Careers
Request a Quote
  • youtube
  • twitter
  • linkedin
Cryoport Systems logo

© 2024 Cryoport Systems, LLC. All rights reserved.
Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC

  • youtube
  • twitter
  • linkedin